DxVx announced on May 16, 2023, the board of directors appointed Yong Gu Lee as the new CEO. The new CEO, Yong Gu Lee, graduated from Hanyang University. He previously served as the leader of sales and marketing strategy teams at Hanmi Pharm.Co.,Ltd, where he established the company's presence in the diabetes and cardiovascular disease business.

He also held positions such as the director of management planning office at Beijing Hanmi Pharm. Co., Ltd., managing director of the healthcare business division at Beijing Medi'Care Co., Ltd. and vice president of the COREE Group. In particular, he is known as a global marketing and sales expert who had played the vital role for the success of healthcare business at Beijing Hanmi Pharm.

Co., Ltd. as well as the COREE Group in China since 2006. In 2022, he led the growth of DxVx's healthcare business, laying the foundation for resuming trading on the stock market. He is highly spoken of his contributions to the company's growth, such as planning the recent antibiotic business in China and launching 12 microbiome-based products.